May 20, 2021 Cellectar Announces Poster Presentation of CLR 131 Data in Waldenstrom’s Macroglobulinemia at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Learn More
May 14, 2021 Cellectar to Participate at the Oppenheimer Rare & Orphan Disease Summit on May 21, 2021 Learn More
May 10, 2021 Cellectar Reports Financial Results for the First Quarter 2021 and Provides a Corporate Update Learn More
Apr 27, 2021 Cellectar Strengthens Global IP Position with Phospholipid Drug Conjugate Composition of Matter Patent in Eurasia, Australia, and Mexico Learn More